icd 10 code for hair loss scalp

Full Answer

What is the CPT code for hair loss?

L65. 9 - Nonscarring hair loss, unspecified. ICD-10-CM.

What is the ICD-10 code for unspecified alopecia?

9: Alopecia areata, unspecified.

What is the medical code for alopecia?

L63. 9 - Alopecia areata, unspecified | ICD-10-CM.

What is the ICD-10-CM code for hair loss?

ICD-10 code L65. 9 for Nonscarring hair loss, unspecified is a medical classification as listed by WHO under the range - Diseases of the skin and subcutaneous tissue .

What is focal hair loss?

Focal hair loss is secondary to an underlying disorder that may cause nonscarring or scarring alopecia. Nonscarring focal alopecia is usually caused by tinea capitis or alopecia areata, although patchy hair loss may also be caused by traction alopecia or trichotillomania.

What is L65 8 code?

Other specified nonscarring hair lossL65. 8 - Other specified nonscarring hair loss | ICD-10-CM.

What is alopecia areata unspecified?

Alopecia areata universalis is the loss of hair over your entire body. Diffuse alopecia areata is a sudden thinning of your hair rather than lost patches. Ophiasis alopecia areata causes hair loss in a band shape around the sides and back of your head.

What is R53 83?

ICD-9 Code Transition: 780.79 Code R53. 83 is the diagnosis code used for Other Fatigue. It is a condition marked by drowsiness and an unusual lack of energy and mental alertness. It can be caused by many things, including illness, injury, or drugs.

What is it called when you don't have any hair?

bald. / (bɔːld) / adjective. having no hair or fur, esp (of a man) having no hair on all or most of the scalp. lacking natural growth or covering.

What can you do for telogen effluvium?

What is the treatment for telogen effluvium?Gentle handling of the hair, avoiding over-vigorous combing, brushing and any type of scalp massage.Treat any underlying scalp disorder or hormonal problem determined, if any.Ensure a nutritious diet, with plenty of protein, fruit and vegetables.More items...

What does non scarring alopecia mean?

Non scarring hair loss, also known as noncicatricial alopecia is the loss of hair without any scarring being present. There is typically little inflammation and irritation, but hair loss is significant.

What is alopecia totalis?

Alopecia totalis is a chronic condition of complete hair loss of the scalp, which affects a small percentage of patients with alopecia areata. Treatment outcomes are best when this disease is recognized and treated early in its course.

How do you diagnose alopecia?

A doctor may be able to diagnose alopecia areata simply by looking at the extent of your hair loss and examining a few hair samples under a microscope. Your doctor may order a scalp biopsy to rule out other conditions that cause hair loss, including fungal infections like tinea capitis.

How do you fix alopecia areata?

There is currently no cure for alopecia areata, although there are some forms of treatment that can be suggested by doctors to help hair re-grow more quickly. The most common form of alopecia areata treatment is the use of corticosteroids, powerful anti-inflammatory drugs that can suppress the immune system.

What is the treatment for alopecia totalis?

Topical immunotherapy is used to treat extensive alopecia areata, alopecia totalis and alopecia universalis. This form of treatment involves applying chemicals such as diphencyprone (DPCP), dinitrochlorobenzene (DNCB) or squaric acid dibutyl ester (SADBE) to the scalp.

Which of the following is the most common cause of hair loss?

The most common cause of hair loss is a hereditary condition that happens with aging. This condition is called androgenic alopecia, male-pattern baldness and female-pattern baldness.

What factors influenced the decision making process of scalp cooling?

Faster regrowth was a motivator to continue treatment. Efficacy and tolerability of scalp cooling influenced future hypothetical treatment decision-making for both scalp-cooled and non-scalp-cooled participants. The authors concluded that this study provided the first in-depth exploration of patient attitudes to scalp cooling. They stated that the findings of this study highlighted a need for accurate information regarding efficacy and tolerability as well as hair care information to assist patients with their treatment decision-making.

How effective is scalp cooling?

Scalp cooling was effective in preventing chemotherapy-induced hair loss in 32 of 62 available patients (52 %). Even though patients knew hair loss was temporary, it was a burden to 54 % of them (n = 100). Scalp cooling was a burden for only 17 out of 51 patients (33 %). Most patients who used a wig or head cover were satisfied with it (82 %, n = 126). Patients were moderately satisfied with the regrowth of their hair after chemotherapy. Successfully cooled patients rated their hair as less important for their body image compared to patients who did experience hair loss (p = 0.014). The authors concluded that chemotherapy-induced hair loss is perceived as burdensome. It may be prevented by offering scalp cooling which is often an effective method to prevent this form of hair loss and is well-tolerated by patients. However, if possible, scalp-cooling techniques should be improved and their effectiveness should be increased because if scalp cooling is unsuccessful, patients' rate their hair loss as more burdensome compared to non-cooled patients.

How many studies were there on scalp cooling?

The literature search identified 192 reports, of which 32 studies were considered relevant.

Can cold caps cause alopecia?

Belum and associates (2016) reported the occurrence of cold thermal injury (frost-bite) on the scalp, following the use of cold caps for the prevention of CIA. These investigators identified 4 patients who developed cold thermal injuries on the scalp following the application of cold caps. Medical records were analyzed to retrieve the demographic and clinical characteristics. The cold thermal injuries in these patients were grade 1/2 in severity and improved with topical interventions and interruption of cold cap use, although grade 1 persistent alopecia ensued in 3 patients. The true incidence of such injuries in this setting, however, remains unknown. The authors concluded that cold thermal injuries are likely infrequent and preventable adverse effects (AEs) that may result from improper device application procedures during cold cap use. They noted that although these untoward events were usually mild-to-moderate in severity, the potential occurrence of long-term sequelae (e.g., permanent alopecia and scarring) or the need to discontinue cold cap use, are not known. They stated that prospective studies are needed to further elucidate the risk and standardize healthcare delivery methods, and to improve patient/supportive/healthcare provider education.

Does scalp protection help with hair loss?

Although scalp protection through cooling or tourniquet has been reported to minimize delivery of chemotherapeutic agents to the scalp, thereby potentially decreasing the risk of hair loss, case reports of cutaneous metastases or spread in some settings prevent general recommendation for their use. Because chemotherapy-associated hair loss is transient and usually (although not always) completely reversible after cessation of therapy, adequate counseling and psychological support for alopecia both before and during therapy should take precedence over the use of such devices".

Is scalp hypothermia effective?

Scalp hypothermia may not be as effective in patients with liver dysfunction . This is likely related to delayed drug metabolism, thereby allowing persistence of therapeutic drug levels beyond the protective period. Scalp cooling is contraindicated in patients with cold sensitivity, cold agglutinin disease, cryoglobulinemia, and post-traumatic cold dystrophy. In addition, some investigators have raised concerns regarding the possibility of scalp metastasis in association with scalp hypothermia. As an example, one group reported the outcome of a patient with mycosis fungoides who used a cooling cap to prevent alopecia. Following chemotherapy, he developed recurrent disease limited to the scalp. Subsequent treatment without a cooling device resulted in complete clinical remission. However, the clinical significance of these findings is unclear in patients with solid tumors. In one study of 61 patients with disseminated breast cancer receiving chemotherapy who used a cooling cap, 1 patient with underlying liver dysfunction developed cutaneous scalp metastasis. In contrast, 3 separate series, either entirely or predominantly consisting of patients receiving adjuvant treatment for breast cancer reported no increased frequency of scalp metastases in the patients who were treated in conjunction with a scalp cooling device. These case reports suggest that cooling devices may be contraindicated in patients with circulating tumor cells (e.g., lymphoma, leukemia) or in those with liver dysfunction resulting in prolonged drug half-lives. They should be used with caution in patients with breast carcinoma, especially in the setting of adjuvant therapy, as well as other carcinomas associated with risk for cutaneous metastases, such as lung, kidney, stomach, colon, and uterus.

Does doxorubicin help with alopecia?

An UpToDate review on "Chemotherapy-induced alopecia" (Payne, 2016) states that "The success of scalp cooling for preventing or reducing chemotherapy- induced alopecia is highly variable between patients and chemotherapy regimens. The drugs best suited to this approach include doxorubicin, daunorubicin, paclitaxel, epirubicin, vincristine, vinblastine, actinomycin D and mechlorethamine. Success with combination regimens such as intravenous cyclophosphamide, methotrexate and fluorouracil (CMF) has been reported, but this approach failed with the combination of doxorubicin plus cyclophosphamide. Results are also dose-dependent, with higher doses of anthracyclines being associated with higher rates of alopecia despite the use of scalp cooling. Results of many studies are difficult to interpret secondary to use of multiple cooling systems (ice turban, gel packs, cool caps, thermocirculator, room air conditioner), variable chemotherapy regimens (single versus combined agents), small study populations, and varying definitions of alopecia. Nevertheless, at least 4 randomized controlled trials suggest significantly less hair loss with scalp hypothermia. In general, between 50 and 80 % of patients have a good to excellent response with this therapy. A meta-analysis of 8 randomized controlled trials and 9 controlled clinical trials involving 1,098 participants (616 interventions and 482 controls) who received a variety of interventions for prevention of chemotherapy-induced alopecia concluded that scalp cooling was the only intervention that significantly reduced the risk of chemotherapy-induced alopecia (relative risk 0.38, 95 % CI: 0.32 to 0.45). No adverse events associated with scalp cooling were reported in the meta-analysis.

What is the ICd code for alopecia?

The ICD code L669 is used to code Cicatricial alopecia. Cicatricial alopecia, also known as scarring alopecia, is a diverse group of rare disorders that destroy the hair follicle, replace it with scar tissue, and cause permanent hair loss. A variety of distributions are possible.

What is the scar on the scalp?

The inflammation that destroys the follicle is below the skin surface and there is usually no "scar" seen on the scalp. Affected areas of the scalp may show little signs of inflammation, or have redness, scaling, increased or decreased pigmentation, pustules, or draining sinuses.

What is the ICD10 code for L66.9?

This means that while there is no exact mapping between this ICD10 code L66.9 and a single ICD9 code, 704.09 is an approximate match for comparison and conversion purposes.

What is billable code?

Billable codes are sufficient justification for admission to an acute care hospital when used a principal diagnosis.

Is hair loss gradual or progressive?

A variety of distributions are possible. In some cases, hair loss is gradual, without symptoms, and is unnoticed for long periods. In other cases, hair loss is associated with severe itching, burning and pain and is rapidly progressive. The inflammation that destroys the follicle is below the skin surface and there is usually no "scar" seen on ...

What is the ICD code for hair loss?

ICD Code L66 is a non-billable code. To code a diagnosis of this type, you must use one of the seven child codes of L66 that describes the diagnosis 'cicatricial alopecia [scarring hair loss]' in more detail. L66 Cicatricial alopecia [scarring hair loss] NON-BILLABLE. BILLABLE.

What is the ICD code for acute care?

Use a child code to capture more detail. ICD Code L66 is a non-billable code.